Advanced Immunological Treatment and Research Medical Center

Cancer Immunotherapy Acknowledged with 2018 Nobel Prize!

In what many are hailing as a paradigm shift in the treatment of cancer, The Nobel Prize in Physiology or Medicine was awarded to James P. Allison of the United States and Tasuku Honjo of Japan for their cutting-edge, exceptional work in developing cancer immunotherapy treatments. Allison, age 70, is from Alice, Texas and currently […]

Continue reading

Learn how CHIPSA is Different!!

Dear Friends, So far 2018 has been a year of great gains in our treatment of cancer at The CHIPSA Hospital. The CHIPSA  Approach™ has been a simple one; forget our ego and preconceived notions of what works in treating cancer and be open to all possibilities. This includes considering both natural and man made […]

Continue reading

Read The Results of The Vallovax Trial at CHIPSA Hospital

Vallovax and CHIPSAIn October of 2017 Chipsa was introduced to Batu Biologics, a San Diego based Biotech company, whose mission aligned with Chipsa’s. How can we harness the power of the immune system to treat cancer? Batu Biologics presented us with a novel therapy. A blood based vaccine that sought to target what many see as […]

Continue reading

Establishment of Immuno-oncology as a Cancer Therapy


Immuno-oncology is set to become one of the most vital cancer treatments, rising up into the realms surgery, chemotherapy, radiotherapy, and other targeted therapies. From their study, “Pharma Focus Visual Analysis of Immuno-Oncology Development and Opportunities”, Global Data was able to reach a conclusion and has analyzed more than 4,000 clinical trials of over 800 […]

Continue reading

A New Modified Molecule Helps to Tailor Effective Anti-Cancer Response

NK cell

  A mouse study published in Cell Chemical Biology reveals that a new version of the foreign fat molecule alpha-galactosylceramide (a-GalCer) is very successful at inducing inflammatory and anti-tumor responses in humans. The results of this study may be helpful in creating treatments that will prevent the spread of cancer. Past studies have shown that synthetic-GalCer, […]

Continue reading